David Smith

David Smith is a partner in Fasken Martineau DuMoulin LLP and Fasken Martineau LLP (London) and a member of the Corporate / Commercial practice group.

David's practice focuses on capital markets and a combination of capital raising and mergers and acquisitions. He also regularly represents entrepreneurial growing companies, both public and private. David has been actively involved in the Alternative Investment Market (AIM) since its inception in 1995, and has acted as company secretary to a number of listed and AIM companies.

David is a skilled communicator who aims to provide practical advice that is sensitive to the needs of his clients at a time when they need cool, calm counsel. He also recognizes the importance of balancing the sophisticated and sometimes taxing demands and business practices of capital providers with the needs of his entrepreneur clients, whose desires are generally focused more on concluding a transaction than on technical detail.

While David represents clients across industries ranging from television to information technology, his practice has some emphasis on the health sciences and natural resources sectors; to that end, he has lectured and written on the application of royalty financing securitization structures in the pharmaceutical industry.

Selected Experience

• Newmont Ventures purchases 10% equity stake in Triple Plate Junction as part of US$15 million joint venture in Papua New Guinea
• Apitope raises EUR 10 million in Series A financing

News

• Legal 500 Directory 2007

Publications

• AIM Review
• Guide to Setting Up Business in the UK

Honours and Awards

• David is listed in Legal Experts 2007, published by Legal Business, as an authority on corporate mergers and acquisitions.
• David is recognised in the Capital Markets 2007/8 handbook, published by Practical Law for his expertise in Equity capital markets: small-mid cap. David "acts for a number of companies in AIM-related transactions", and "has a wealth of experience in this area".